Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01WDS
|
||||
Former ID |
DNC008441
|
||||
Drug Name |
4-(cyclohexylamino)-N-(quinolin-3-yl)benzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529389] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H23N3O
|
||||
Canonical SMILES |
C1CCC(CC1)NC2=CC=C(C=C2)C(=O)NC3=CC4=CC=CC=C4N=C3
|
||||
InChI |
1S/C22H23N3O/c26-22(25-20-14-17-6-4-5-9-21(17)23-15-20)16-10-12-19(13-11-16)24-18-7-2-1-3-8-18/h4-6,9-15,18,24H,1-3,7-8H2,(H,25,26)
|
||||
InChIKey |
SWEAAERORIFOIX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Inhibitor | [529389] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.